Alerts will be sent to your verified email
Verify EmailAVIENCE
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Avience Biomedicals has emerged as an innovative diagnostics solutions provider. Recognized as a Startup and a Small-scale Industry under MSME, the company is committed to empowering healthcare professionals with advance technology.
Avience Biomedicals major competitors are Morepen Laboratories.
Market Cap of Avience Biomedicals is ₹0 Crs.
While the median market cap of its peers are ₹2,839 Crs.
Avience Biomedicals seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | |||||||||||||||||||
| Investor Presentation | |||||||||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Claude
|
